Antimicrobial resistance in ocular infection: A review

  20 March 2024

Antimicrobial resistance (AMR) is a global public health threat affecting treatment outcomes. The World Health Organization’s Global Action Plan recommends strengthening the evidence base through surveillance programs and research. Comprehensive data on AMR in ocular infections is needed to guide treatment decisions and inform researchers and microbiologists of emerging trends. Common ocular pathogens include Pseudomonas aeruginosa, Staphylococcus spp., Streptococcus pneumoniae, and Haemophilus influenzae. Fluoroquinolone resistance has increased in Asia and North America, while ciprofloxacin resistance has decreased in conjunctivitis and keratitis. Methicillin-resistance and multidrug resistance are emerging, requiring ongoing monitoring. Antimicrobial stewardship (AMS) programs play a critical role in reducing AMR threats and improving treatment outcomes.

Further reading: Clin Exp Ophtalmol
Author(s): Maria Cabrera-Aguas et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed